中文
|
English
Home
|
Help
|
Contact
Return
Why should we monitor for hematologic adverse drug reactions to oxcarbazepine?
10.3345/kjp.2019.00472
Author:
Gwang Cheon JANG
1
Author Information
1. Department of Pediatrics, National Health Insurance Service Ilsan Hospital, Goyang, Korea. janggwangc@yuhs.ac
Publication Type:
Editorial
MeSH:
Drug-Related Side Effects and Adverse Reactions
From:
Korean Journal of Pediatrics 2019;62(8):299-300
Country
Republic of Korea
Language:
English
Abstract:
No abstract available.